PharmaBlock Sciences (Nanjing), Inc. Stock: price and insider trades · China
药石科技
No insider purchase over the last 90 days. The latest, by 杨民民, was filed 23 Aug 2024.
PharmaBlock Sciences (Nanjing), Inc.: what insiders have been doing
PharmaBlock Sciences (Nanjing), Inc. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). The past year has been quiet: not a single insider filing for PharmaBlock Sciences (Nanjing), Inc. The previous disclosure was published on 23 August 2024.
Our records for PharmaBlock Sciences (Nanjing), Inc. go back to 2021, with 2 purchases and 2 sales on the open market in total.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Since the insiders bought
- +79.6%Entry CN¥26.18 · Close at T+365 CN¥47.02
- -14.1%Entry CN¥96.21 · Close at T+365 CN¥82.65
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate PharmaBlock Sciences (Nanjing), Inc. Strong Buy (bullish).
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 87,300 shares100.0% of flowA股XSHESZSE:173000008006723140Canonical exit: 21 Nov 2024 (T+90)
- 800 shares48.9% of flowA股XSHESZSE:173000005388067000
- 800 shares51.1% of flowA股XSHESZSE:173000005388067040Canonical exit: 22 Jun 2022 (T+90)
- 13,000 shares100.0% of flowA股XSHESZSE:173000005016456130
4 of 4 declarations
About PharmaBlock Sciences (Nanjing), Inc.
药石科技 is a company focused on the health and pharmaceutical sector, providing innovative solutions for disease treatment. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
